Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026)
Ludwig Enterprises' (LUDG) quarterly Cash from Financing Activities came in at $170982.0 in Q1 2026, up 72.03% YoY from $99392.0 in Q1 2025, and up 1590.05% on a QoQ basis from $10117.0 in Q4 2025.
Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Ludwig Enterprises (LUDG) has 5 years of Cash from Financing Activities data on file, last reported at $170982.0 in Q1 2026.
- Quarterly Cash from Financing Activities rose 72.03% year-over-year to $170982.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $718857.0 (up 125.98% YoY) and the FY2025 annual result came in at $647267.0, up 15.85% from the prior year.
- Cash from Financing Activities grew to $170982.0 in Q1 2026, from $10117.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $755000.0 in Q4 2022 to a low of $10117.0 in Q4 2025.
- A 5-year average of $215632.5 and a median of $99708.0 in 2024 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 532.66% in 2025, down 89.85% in 2025.
- Tracing LUDG's Cash from Financing Activities over 5 years: stood at $755000.0 in 2022, then sank by 77.48% to $170000.0 in 2023, then slumped by 41.35% to $99708.0 in 2024, then slumped by 89.85% to $10117.0 in 2025, then jumped by 1590.05% to $170982.0 in 2026.
- The last three Cash from Financing Activities figures came in at $170982.0 (Q1 2026), $10117.0 (Q4 2025), and $537758.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Ludwig Enterprises | 1.67 Mn | 1.67 Mn | - | 170,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,982.00 |
| Mar 31, 2026 | 170,982.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Jun 30, 2025 | 537,758.00 |
| Jun 30, 2025 | 537,758.00 |
| Mar 31, 2025 | 99,392.00 |
| Mar 31, 2025 | 99,392.00 |
| Dec 31, 2024 | 99,708.00 |
| Dec 31, 2024 | 99,708.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Mar 31, 2023 | 70,000.00 |